India’s Pharma Industry Raises Concerns Of Shortage & Costlier Medicine For Americans Over Proposed US Tariffs
The Indian pharmaceutical industry has raised alarms over the potential imposition of US tariffs on pharmaceutical exports, warning that such a move could lead to increased drug costs and potential…
US Tariffs on pharma: What are the potential impact on Indian drugmakers
US tariffs on pharmaceutical imports by the US President Donald Trump have sparked concerns within India’s pharma sector, a global leader in affordable generic drug supplies. In an exclusive interaction…
Cipla To Invest Rs 415 Crore In South African Arm To Improve Capital Structure
The pharmaceutical company reported a consolidated net profit of Rs 1,571 crore for the quarter ending in December. This exceeded the Bloomberg-tracked analysts’ consensus estimate of Rs 1,208 crore. The…
Indian Pharma Market Reaches Rs 19,083 Crore In December, Check Out Top Performing Brands
New Delhi: The Indian Pharmaceutical Market (IPM) has experienced robust growth, reaching a market value of Rs 19,083 crore in December 2024. This marks a 7.68% increase compared to the previous…
Cipla rolls out mobile application for asthma screening
Drug firm Cipla on Monday said it has launched a mobile application designed to enable the first line of screening for asthma in India. According to the Global Burden of Disease report,…
NPPA Fixes Retail Price Of 51 Formulations, Details
New Delhi : Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail price of 51 formulations, including…
Efficient warehouse & inventory management to reduce risk of compliance violations: Harish K Jain
Efficient warehouse and inventory management are crucial for the pharmaceutical industry. Data-driven decision making, cost efficiency, improved product availability, regulatory compliance, minimized risk of stock-outs, effective management of warehouses and…
Drug overpricing: Govt plans amnesty scheme to recover dues from pharma companies
In a bid to tackle overpricing in the pharmaceutical sector, the government is planning an amnesty scheme to recover dues from pharmaceutical companies, CNBC Aawaz reported. The National Pharmaceutical Pricing Authority (NPPA), responsible for…
Cipla clarifies on promoter stake sale; for personal and philanthropic purposes
Drugmaker Cipla has said that its promoters Dr Y K Hamied, Chairman and MK Hamied, Vice Chairman who are Non-Executive Directors, have sold 2.5 percent stake in the company for…
Cipla Launches Covid-19 Antibody Detection Kits In India
NEW DELHI : Drug firm Cipla on Wednesday announced the launch of antibody detection kits for COVID-19 in India under the brand name ‘ELIFast’ in partnership with KARWA Ltd, under the…
